The store will not work correctly when cookies are disabled.
2,6-ditert-butyl-4-[(2,4-dinitrophenyl)hydrazono]cyclohexa-2,5-dien-1-one
ID: ALA4525036
Cas Number: 14980-56-4
PubChem CID: 350349
Max Phase: Preclinical
Molecular Formula: C20H24N4O5
Molecular Weight: 400.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)C1=CC(=NNc2ccc([N+](=O)[O-])cc2[N+](=O)[O-])C=C(C(C)(C)C)C1=O
Standard InChI: InChI=1S/C20H24N4O5/c1-19(2,3)14-9-12(10-15(18(14)25)20(4,5)6)21-22-16-8-7-13(23(26)27)11-17(16)24(28)29/h7-11,22H,1-6H3
Standard InChI Key: CWZZBEWTIRHVCF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
5.5457 -5.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2534 -4.9939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9653 -5.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9653 -6.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2534 -6.6321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5457 -6.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2534 -7.4509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5460 -7.8623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5460 -8.6769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2533 -9.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2564 -9.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5445 -10.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8410 -9.9089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8342 -9.0908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1267 -8.6794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1267 -7.8607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4193 -9.0908 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5445 -11.1301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8371 -11.5415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2560 -11.5415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6727 -4.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6727 -4.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3802 -5.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3802 -4.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2534 -4.1752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8382 -4.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1308 -5.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8382 -4.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1308 -4.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 1 0
1 6 2 0
5 7 2 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
15 14 1 0
15 16 1 0
15 17 2 0
18 12 1 0
18 19 1 0
18 20 2 0
3 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
2 25 2 0
1 26 1 0
26 27 1 0
26 28 1 0
26 29 1 0
M CHG 4 15 1 16 -1 18 1 19 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.44 | Molecular Weight (Monoisotopic): 400.1747 | AlogP: 4.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 127.74 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.44 | CX Basic pKa: 4.26 | CX LogP: 6.52 | CX LogD: 6.52 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.44 | Np Likeness Score: -0.87 |